secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2022-01-06T23:59:59+00:00
Accession:  0001193125-22-003643
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Agenus President and COO Jennifer Buell resigns to lead subsidiary MiNK Therapeutics
--------------------------------------------------------------------------------

- Dr. Jennifer Buell resigned as President and COO effective December 31, 2021.
- She becomes President and CEO of MiNK Therapeutics, a subsidiary of Agenus.
- Buell will also serve on Agenus' Executive Council to advise on pipeline synergy.
- No successor as President/COO announced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/0001193125-22-003643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000119312522003643/d646332d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-003643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer